FBI-1 Enhances Transcription of the Nuclear Factor-B (NF-B)-responsive E-selectin Gene by Nuclear Localization of the p65 Subunit of NF-B*
The BTB/POZ (broad complex, Tramtrack, and bric-a-brac/ poxvirus and zinc finger) domain is an evolutionarily conserved protein-protein interaction domain that is found at the N terminus of various cellular and viral regulatory proteins. The proteins containing the BTB/POZ domain have several C-terminal structures important in their biological functions, such as the zinc finger, actin-binding repeats, and ion channel motifs (1) (2) (3) . The POZ domains of PLZF (promyelocytic leukemia zinc finger) and Bcl-6 (B-cell lymphoma-6) have been shown to interact with SMRT (silencing mediator for retinoid and thyroid hormone receptors)/N-CoR (nuclear receptor co-repressor), mSin3A, and histone deacetylases (4, 5) .
FBI-1 (factor that binds to the inducer of short transcripts of human immunodeficiency virus-1) was purified as a cellular factor that binds specifically to the wild-type IST (inducer of short transcripts) elements of human immunodeficiency virus-1 long terminal repeats and the proximal promoter of the ADH5/FDH gene, and its cDNA was cloned (6 -9) . FBI-1 is a ubiquitous transcription factor that contains a BTB/POZ domain at its N terminus and Krü ppel-like zinc fingers at its C terminus. There have been several recent reports on the function of FBI-1. FBI-1 stimulates Tat (transactivator of transcription) activity on the human immunodeficiency virus-1 long terminal repeat (8) and represses human ADH5/FDH gene expression by interacting with Sp1 zinc fingers (9) . The mouse counterpart of FBI-1, LRF (leukemia/lymphoma-related factor), is co-immunoprecipitated and co-localized with Bcl-6 (10). The rat homolog of FBI-1, OCZF (osteoclast-derived zinc finger), is a transcription repressor and is involved in osteoclastogenesis (11) . SAGE (serial analysis of gene expression) analysis shows that the expression of FBI-1 is increased in cancer tissues (available at www.ncbi.nlm.nih.gov/UniGene/ clust.cgi?ORGϭHs&CIDϭ104640).
Nuclear factor-B (NF-B) 1 exists in homo-or heterodimeric form and is an inducible transcription factor that activates the transcription of a variety of genes with the 10-bp consensus sequence GGGRNNYYCC (where R is purine, Y is pyrimidine, and N is any base) in the promoter in response to infection, inflammation, and stress conditions (12) (13) (14) (15) . NF-B exists in the cytoplasm of most cell types as the homo-or heterodimer of structurally related proteins called the Rel or Rel/NF-B proteins. It appears that various Rel/NF-B complexes have different NF-B binding site specificities and that the extent of transcription induced by individual subunit combinations is, in part, dependent upon the nature of binding sites that they recognize. The Rel/NF-B proteins contain a highly conserved N-terminal 300-amino acid region called the Rel homology domain (RHD). The RHD contains important domains for DNA binding, dimerization, the nuclear localization sequence (NLS), and interaction with IB (inhibitor of NF-B) family members (12) (13) (14) (15) . In non-stimulated cells, NF-B complexes are sequestered in the cytoplasm in an inactive form via interaction with a monomer of an inhibitory protein called IB, which itself belongs to a structurally and functionally related family of proteins (14, 16, 17) .
The IB family of inhibitory proteins of NF-B includes IB␣, IB␤, IB␥, IB⑀, Bcl-3, and the precursor Rel proteins p100 and p105 (14, 18) . These proteins not only specifically and reversibly inhibit DNA binding by NF-B, but also actively dissociate DNA-bound NF-B in vitro and export back to the cytoplasm (19) . IB␣ and IB␤ are important regulators of mammalian NF-B (20) . All IB proteins contain three to seven ankyrin repeat sequences of 30 -33 amino acids, and the repeats mediate the binding of IB proteins to the RHD of NF-B. The direct protein-protein interaction between ankyrin repeats of IB proteins and the RHD mask the NLS and prevent the nuclear translocation of NF-B (12, 17, 22, 23) . The C-terminal PEST sequences and N termini of IB proteins contain serine phosphorylation and ubiquitination sites, which are important for the signal-induced degradation of IB proteins and the release of NF-B from cytoplasm trapping (24, 25) .
In non-stimulated cells, NF-B exists in an inactive form, having been bound to a member of the IB family in the cytoplasm (18, 23, 26) . When cells are exposed to various stimuli such as cytokines (e.g. tumor necrosis factor-␣ (TNF␣) and interleukin-1), bacterial or viral products (e.g. lipopolysaccharide), and pro-apoptotic or necrotic stimuli (e.g. UV light and ␥-irradiation) (Refs. 14, 18, and 29 and references therein), IB is phosphorylated by a specific IB kinase complex (27, 28) . The phosphorylation of IB proteins by the IB kinase complex triggers polyubiquitination by a specific ubiquitin ligase belonging to the SCF (Skp-1/Cul/F-box) family (29) . As soon as the IB proteins are polyubiquitinated, they are rapidly degraded by the 26 S proteasome. The released NF-B enters the nucleus, binds to target promoters, and activates transcription (14, 18, 29) .
Here, we report that FBI-1 interacts with the RHD of the p65 subunit of NF-B. The interactions increase the localization and stability of the p65 subunit in the nucleus, resulting in the transcription enhancement of an NF-B-responsive target gene such as E-selectin.
EXPERIMENTAL PROCEDURES
Plasmids, Antibodies, and Reagents-Mammalian expression vectors for the human p65 subunit, IB␣, IB␤, and NF-B reporter plasmids were kind gifts from Drs. T. H. Lee and K. C. Jung (Yonsei University). The overexpression plasmids for the p65 subunit of NF-B, IB␣, and IB␤ are under the control of the cytomegalovirus promoter, and the pELAM-Luc plasmid was described previously (24) . pcDNA3.0-FBI-1 and pcDNA3.0-POZ FBI-1 were reported elsewhere (9). pcDNA3.0-POZ NLS was prepared by attaching the NLS sequence (amino acids 487-505, KDGC-NGVPSRRGRKPRVRG) of FBI-1 to the POZ domain (amino acids 1-133). For bacterial overexpression, His 6 -RHD and GST-POZ cDNAs were cloned into pQE30 (Qiagen Inc.) and pGEX4T3 (Amersham Biosciences) expression vectors. All plasmid constructs were verified by sequencing.
Anti-His 6 antibody was purchased from Qiagen Inc. Anti-p65 subunit, anti-phosphorylated p65 subunit, anti-IB␣, and anti-IB␤ antibodies were from New England Biolabs Inc. (Beverly, MA), Upstate Biotechnology Inc. (Charlottesville, VA), and Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Fluorescein isothiocyanate (FITC)-conjugated anti-rabbit and rhodamine-conjugated anti-mouse secondary antibodies were obtained from Jackson ImmunoResearch Laboratories, Inc. (West Grove, PA). Horseradish peroxidase-conjugated anti-rabbit antibody was from Bio-Rad, and horseradish peroxidase-conjugated anti-mouse antibody was from Santa Cruz Biotechnology, Inc. Anti-glyceraldehyde-3-phosphate dehydrogenase antibody was purchased from Chemicon International, Inc. (Temecula, CA). TNF␣, MG132 (benzyloxycarbonyl-leucinyl-leucinyl-leucinal), ammonium pyrrolidinedithiocarbamate (PDTC), Me 2 SO, GSH-agarose, p-phenylenediamine, and phorbol 12-myristate 13-acetate (PMA) were obtained from Sigma. Rabbit polyclonal antibody against the POZ domain of FBI-1 was prepared by us (9) .
Yeast Two-hybrid Screening of Polypeptides Interacting with the POZ Domain of FBI-1-To perform the yeast two-hybrid screening, we used the Matchmaker® LexA two-hybrid system and cDNA library (Clontech). The POZ domain of FBI-1 was cloned into a pLexA-DB vector and used as bait. The PCR-amplified POZ domain of FBI-1 was cloned into the pLexA vector. The pLexA-POZ FBI-1 plasmid was introduced into yeast strain EGY48(p8op-lacZ) by a standard protocol, and yeast containing pLexA-POZ FBI-1 was selected on synthetic dextrose/ϪUra/ϪHis plates. Transformed yeast containing pLexA-POZ FBI-1 was prepared as competent yeast by a standard protocol. An amplified human liver Matchmaker® yeast LexA cDNA library was transformed into competent pLexA-POZ FBI-1 -containing yeast and screened on synthetic dextrose/ϪUra/ϪHis/ϪTrp plates. At 5 days post-transformation, 153 well grown colonies were selected and stored. The cotransformants of the 153 colonies were screened on synthetic dextrose/Gal/Raf/ϪUra/ϪHis/ ϪTrp/ϪLeu ϩ X-gal to identify the protein-protein interactions. After nutrition and X-gal double selection, 37 colonies were isolated. The plasmids in the yeast were isolated by miniscale preparation and transformed into Escherichia coli DH5␣. The amplified plasmids from E. coli were purified, restriction enzyme-digested for mapping, and sequenced.
Molecular Interaction between IB␣ or IB␤ and the POZ Domain of FBI-1 in Yeast Two-hybrid Assays-The POZ domain of FBI-1 was cloned into the pLexA-DB vector to prepare pLexA-POZ FBI-1 and used as bait. The pLexA-POZ FBI-1 plasmid was introduced into yeast strain EGY48(p8op-lacZ) by a standard protocol, and yeast containing pLexA-POZ FBI-1 was selected on synthetic dextrose/ϪUra/ϪHis plates. Transformed yeast containing pLexA-POZ FBI-1 was prepared as competent yeast by a standard protocol. To prepare the fish protein pB42AD-IB␤ plasmid, the coding sequence of IB␤ was amplified by PCR and cloned into the pB42AD vector in-frame with the B42 activation domain. Yeast cotransformants of two plasmids (pLexA-POZ FBI-1 and pB42AD-IB␤) were streaked onto synthetic dextrose/Gal/Raf/ϪUra/ϪHis/ϪTrp ϩ Xgal, and the in vivo protein-protein interactions were identified by blue colony formation.
Bacterial Overexpression of Fusion Proteins and in Vitro ProteinProtein Interaction Assays-For bacterial overexpression of fusion proteins, the pTrcHisB-RHD (the RHD of the p65 subunit of NF-B) and pGEX4T3-POZ FBI-1 plasmids were transformed into E. coli DH5␣. Bacteria were grown in 500 ml of LB broth to A 600 ϭ 0.8 at 37°C and induced overnight with 0.2 mM isopropyl ␤-D-thiogalactopyranoside at 18°C. Bacteria were collected by centrifugation and lysed in cold E. coli binding buffer (50 mM Tris-HCl (pH 8.0), 300 mM NaCl, 1% Nonidet P-40, 10 mM imidazole, and one tablet/50 ml protease inhibitor mixture (Roche Applied Science)). Soluble fractions from the lysate were incubated with 2 ml of GSH-agarose (for GST-POZ) or 500 l of nickelnitrilotriacetic acid (for His 6 -RHD; Qiagen Inc.) for 1 h at 4°C. After washing, bound proteins were eluted with 2 ml of elution buffer (for GST-POZ, 10 mM GSH and 50 mM Tris-HCl (pH 8.0); and for His 6 -RHD, 50 mM Tris-HCl (pH 8.0), 300 mM NaCl, and 100 or 250 mM imidazole) and dialyzed with cold phosphate-buffered saline (PBS) for 1 h at 4°C.
For the in vitro protein-protein interaction assay, 9 g of purified GST-POZ and GST were bound to GSH-agarose for 1 h in 500 l of TNE buffer (50 mM Tris-HCl (pH 8.0), 1% Nonidet P-40, 2 mM EDTA, and one tablet/50 ml protease inhibitor mixture) at 4°C. Agarose-bound GST or GST fusion protein was collected by centrifugation at 3000 ϫ g for 1 min at 4°C and washed four times with cold TNE buffer. Agarose-bound GST protein was incubated with His 6 -RHD in TNE buffer for 1 h at 4°C. After the agarose-protein complex was washed three times with cold TNE buffer, the bound proteins were resolved by 15% SDS-PAGE and subjected to Western blot analysis using anti-Xpress tag antibody.
Recombinant GST-IB␣, GST-IB␤, and His 6 -POZ proteins were prepared as described above using the pGEX4T3-IB␣, pGEX4T3-IB␤, and pQE30-His-POZ expression plasmids, respectively. For the in vitro protein-protein interaction assay, 9 g of purified GST-IB␣ or GST-IB␤ and GST were bound to GSH-agarose for 1 h in 500 l of TNE buffer at 4°C. Agarose-bound GST or GST fusion protein was collected by centrifugation at 3000 ϫ g for 1 min at 4°C and washed four times with cold TNE buffer. Agarose-bound GST protein was incubated with His 6 -POZ in TNE buffer for 1 h at 4°C. After the agarose-protein complex was washed three times with cold TNE buffer, the bound proteins were resolved by 15% SDS-PAGE and subjected to Western blot analysis using anti-His tag antibody.
Cell Culture and Transient Transfection-HeLa cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum. For the transient transfection study, HeLa cells were seeded onto 6-well plates and grown for 24 h before transfection with a total of 1 g of DNA (0.6 g of pELAM-Luc, 0.2 g of FBI-1 or POZ domain expression plasmid, and 0.2 g of pCMV-␤-gal) using Lipofectamine Plus reagent (Invitrogen). Cells were harvested 48 h after transfection, and TNF␣ (20 ng/ml) or PMA (250 ng/ml) was introduced 4 h before harvesting the cells. Cells were lysed in reporter lysis buffer, and luciferase activities were measured using the luciferase assay system (Promega). Luciferase activity was normalized to ␤-galactosidase activity.
To investigate whether the POZ domain of FBI-1 is sufficient to affect the cellular localization of the p65 subunit of NF-B and to activate transcription of the E-selectin promoter, HeLa cells were transfected with a total of 1.2 g of DNA (0.2 g of pELAM-Luc, 0.4 g of POZ or POZ NLS domain expression plasmid, 0.2 g of pCMV-␤-gal, and the appropriate amount of pcDNA3.0 to make a total of 1.2 g of DNA) using Lipofectamine Plus reagent as described above.
Immunostaining-For immunostaining, PMA-stimulated or nonstimulated HeLa cells were grown on coverslips (Sunshine Works, Seoul, Korea), washed with cold PBS, and fixed in 99:3 cold methanol/ formaldehyde for 20 min at Ϫ20°C. Cells were permeabilized in 0.2% Triton X-100 for 10 min at room temperature and then washed three times for 10 min each with PBS. Cells were incubated in 5% normal goat serum (Invitrogen) for 30 min at room temperature. After blocking, the cells were incubated in a wet chamber with rabbit anti-POZ domain primary antibody (diluted to a final concentration of 5 g/ml) in an incubation solution of 1% bovine serum albumin and 0.02% sodium azide in PBS for 2 h at room temperature. Cells were then rinsed three times for 10 min each with the incubation solution and further incubated with rhodamine-conjugated anti-rabbit IgG secondary antibody (diluted to 5 g/ml; Jackson ImmunoResearch Laboratories, Inc.) for 1 h at room temperature. For double staining, after the cells were washed with PBS, they were incubated with 3.7% formaldehyde. The cells were then incubated with different antibodies (anti-p65 subunit primary antibody (diluted to a final concentration of 5 g/ml) and FITC-conjugated anti-mouse IgG secondary antibody) and washed three times for 10 min at room temperature, with the final wash containing 1 mg/ml 4Ј,6-diamidino-2-phenylindole. Cells were mounted onto slide glasses with mounting medium (90% (v/v) glycerol, 1 mg/ml p-phenylenediamine, and 0.02% sodium azide) and examined with a Carl Zeiss LSM 510 confocal laser scanning microscope.
Immunoprecipitation and Western Blot Analysis-One microgram of anti-p65 subunit polyclonal antibody, anti-IB␣ or anti-IB␤ antibody, or control anti-IgG antibody was incubated overnight at 4°C with 1 mg of cell extract prepared using lysis buffer (20 mM Tris (pH 7.9), 1.0% Triton X-100, 1 mM Na 3 VO 4 , 137 mM NaCl, 1 g/ml leupeptin, 1 g/ml aprotinin, 1 mM sodium orthovanadate, 1 mM EGTA, 10 mM NaF, 1 mM tetrasodium pyrophosphate, 5 mM EDTA, 10% glycerol, 1 mM glycerophosphate, 0.1 g/ml p-nitrophenyl phosphate, and 0.2 mM phenylmethylsulfonyl fluoride). Forty microliters of a 1:1 suspension of protein A-Sepharose beads were added to the cell lysate and incubated for 2 h at 4°C with gentle rotation. The beads were pelleted and washed three times with cell lysis buffer. Bound proteins were dissociated by boiling the samples in 1ϫ PAGE sample buffer (12 mM Tris-HCl, 5% glycerol, 0.4% SDS, 2.88 mM mercaptoethanol, and 0.02% bromphenol blue). The whole cell lysates were separated on a 10% SDS-polyacrylamide gel and transferred to a nitrocellulose membrane (Amersham Biosciences). The membranes were blocked in TBST buffer (20 mM Tris (pH 7.6), 137 mM NaCl, and 0.05% Tween 20) containing 5% nonfat dry milk for 1 h and then incubated overnight at 4°C in 5% nonfat dry milk containing anti-POZ domain antibody. The membrane was washed several times with TBST buffer and incubated with horseradish peroxidase-conjugated anti-rabbit secondary antibody. After 1 h, the blot was washed several times with TBST buffer and developed with ECL reagents (Amersham Biosciences).
RESULTS

FBI-1 Interacts with the p65 Subunit of NF-B-
We screened a human liver Matchmaker® yeast LexA two-hybrid cDNA library using the LexA-POZ domain fusion protein as bait. We isolated the p65 subunit of NF-B as one of the potential proteins interacting with the POZ domain. Accordingly, we investigated whether FBI-1 can interact with NF-B by in vivo co-immunoprecipitation and in vitro GST fusion protein pulldown assay. We transiently transfected HeLa cells with either the pcDNA3.0-FBI-1 overexpression plasmid or the mock expression plasmid (pcDNA3.0). We immunoprecipitated cell extracts with anti-p65 subunit antibody, and precipitants were separated on a 12% SDS-polyacrylamide gel and analyzed by Western blotting using anti-FBI-1 antibody. p65 interacted with FBI-1, and overexpression of FBI-1 led to a stronger FBI-1 band at 75-80 kDa (Fig. 1A) .
To investigate whether the protein-protein interaction between the POZ domain of FBI-1 and p65 is direct, we performed an in vitro GST fusion protein pull-down assay. Recombinant GST or GST-POZ was allowed to interact with His 6 -RHD-Xpress, pulled down, and analyzed by Western blotting using anti-Xpress tag antibody. Our data show that the POZ domain of FBI-1 and the RHD of the p65 subunit interacted directly (Fig. 1B) .
FBI-1 Enhances NF-B-mediated Transcription of the E-selectin Promoter in HeLa Cells Stimulated with Either TNF␣ or PMA, and the POZ Domain of FBI-1 Represses Transcription-
The molecular interaction between FBI-1 and the p65 subunit of NF-B suggests that FBI-1 may play a role in NF-B-mediated transcription activation. To investigate this possibility, we tested the effect of overexpression of FBI-1 and the POZ domain (the FBI-1 functional domain interacting with NF-B) on NF-B-mediated transcription using a luciferase reporter assay. After 44 h of cotransfection of HeLa cells with the NF-Bresponsive E-selectin promoter-luciferase reporter gene fusion plasmid ( Fig. 2A) (30) and the FBI-1 or POZ domain expression plasmid, cells were stimulated with either TNF␣ or PMA for 4 h and harvested. In mock-transfected cells, reporter activity was increased by 6 -10-fold due to the movement of NF-B by the stimulants, as reported by others (40). Interestingly, fulllength FBI-1 further enhanced transcription by 1.7-2-fold compared with the stimulated control (Fig. 2, B and C, bars 2 and  3) . We overexpressed the POZ domain of FBI-1, which lacks the NLS and which is located only in the cytoplasm, and found that the domain repressed transcription by Ͼ70% compared with GST fusion protein pull-down assay. GST or GST-POZ FBI-1 bound to agarose beads was incubated with His 6 -and Xpress-tagged RHD, pulled down, and analyzed by Western blotting using anti-Xpress tag antibody. GST-POZ interacted with the RHD. However, GST did not bind the RHD. The same blot was also analyzed by Western blotting using anti-GST antibody to show equal loading of GST and GST-POZ in the binding reactions. This assay was repeated three times.
the control mock-transfected cells treated with TNF␣ or PMA (Fig. 2, B and C, bars 4) .
We then investigated whether the regulatory property of FBI-1 for NF-B-mediated transcription is unique to FBI-1 or whether the property is generally applicable to other regulatory proteins with a POZ domain. We cotransfected HeLa cells with expression plasmids for various POZ domains or with full-length expression plasmids for PLZF, Bcl-6, MIZ-1 (Myc-interacting zinc finger protein-1), IPP (an actin-binding protein, murine intracisternal A-particle-promoted placenta-expressed protein; Swiss-Prot accession number P28575), and the NF-B-responsive E-selectin promoter-reporter plasmid. Bcl-6, PLZF, and MIZ-1 have POZ domains at their N termini and zinc fingers at their C termini and are well characterized transcription factors (4, 5, 31) . IPP has a POZ domain at its N terminus and Kelch repeats at its C terminus, which are critical in actin binding (32) . Full-length PLZF and IPP repressed transcription by 50 and 23%, respectively (Fig. 2D, bars 4 and 7) . However, other POZ domain proteins such as Bcl-6 and Kelch did not show any effect on transcription and did not affect transcription activation triggered by PMA. The POZ domains of PLZF and MIZ-1 repressed reporter activity by 30% (Fig. 2E, bars 4 and 6) . However, the POZ domains of Bcl-6 and IPP did not show repression (Fig. 2E, bars 5  and 7) . In general, the other POZ domains showed either weak or no repression, and the POZ domain of FBI-1 showed the most potent repression, suggesting that some POZ domains have variable degrees of regulatory properties for NF-B-mediated transcription and that some POZ domains do not have transcription repressor activity.
These data suggest that the transcription enhancement by FBI-1 of the NF-B-responsive E-selectin promoter is unique to FBI-1. Although some POZ domains showed repressive effects similar to the POZ domain of FBI-1, their activities in the full-length versions were different, and none of them enhanced transcription of the E-selectin promoter. PZLF repressed transcription both in the POZ domain form and in the full-length version. IPP did not affect transcription in the POZ domain form, but slightly repressed transcription in the full-length form. Bcl-6 did not show any effect in either form.
Full-length FBI-1 Antagonizes Transcription Repression by IB Proteins, and the POZ Domain of FBI-1 Cooperates with IB␣ or IB␤ in Transcription
Repression-The POZ domain of FBI-1 interacted with the p65 subunit, and full-length FBI-1 enhanced transcription of the NF-B-responsive E-selectin gene promoter. In contrast, the POZ domain repressed transcription of the same NF-B-responsive E-selectin gene and, in this respect, acted as a dominant-negative mutant of fulllength FBI-1. We were puzzled by this observation and tried to address how the molecular interaction among the POZ domain of FBI-1, NF-B, and IB affects the transcription process that involves NF-B. As the molecular interaction between IB␣ or IB␤ and NF-B in the cytosol and the molecular events affecting the interaction are important in the nuclear localization of NF-B and transcription activation, we investigated the relationship among the three factors (IB proteins, the POZ domain, and NF-B) by overexpressing each component and analyzing transcription of the NF-B-responsive E-selectin gene. PMA treatment greatly activated transcription, and FBI-1 fur- ther increased transcription by 2-fold (Fig. 3A, bars 2 and 3) . FBI-1 may increase nuclear import or stay free of NF-B induced by PMA treatment. The transcription of mock-transfected cells (transfected only with the pELAM-Luc plasmid and treated with PMA) was repressed by the presence of IB␣ or IB␤, but this repression was reversed by cotransfection with the FBI-1 expression plasmid. FBI-1 significantly relieved transcription repression by IB␣ and IB␤ by 26.7 and 18%, respectively, in the presence of PMA (Fig. 3A, bars 4 -7) , suggesting that, although ectopic IB proteins inhibited transcription activation by PMA, FBI-1 probably affected the cellular localization of NF-B freed by PMA treatment and enhanced transcription.
We next investigated the function of the POZ domain itself. The POZ domain, IB␣, and IB␤ were able to repress transcription by 56, 28, and 74%, respectively (Fig. 3B, bars 3, 4 , and 6). Transcription repression by IB␣ and IB␤ was further intensified by 74 and 85%, respectively, by the overexpressed POZ domain, suggesting a cooperative role in transcription repression (Fig. 3A, bars 5 and 7) . The data suggest that the POZ domain most likely represses transcription via a mechanism similar to that of IB proteins.
Full-length FBI-1 has an NLS, whereas the POZ domain does not, and this difference may explain the opposite behaviors in transcription of the NF-B-responsive gene. Our results suggest that the molecular interaction between the POZ domain of FBI-1 and the p65 subunit of NF-B affects NF-Bmediated gene transcription. Full-length FBI-1 may increase the nuclear localization of NF-B, whereas the POZ domain of FBI-1 may interact with and trap NF-B in the cytoplasm, just like IB proteins.
Therefore, we prepared a plasmid vector (pcDNA3.0-POZ NLS ) expressing the POZ domain fused to the NLS of FBI-1 (amino acids 487-505, KDGCNGVPSRRGRKPRVRG) and tested whether the POZ NLS domain can, like full-length FBI-1, enhance transcription of the NF-B-responsive E-selectin promoter (Fig.  4A) (9) . Indeed, the POZ NLS domain enhanced transcription by ϳ1.7-fold in the presence of PMA, just like FBI-1, whereas the POZ domain with no NLS repressed transcription by 40% (Fig.  4B) . The presence of the POZ domain reduced transcription enhancement by the POZ NLS domain to the POZ domain-only level (Fig. 4B, bar 8 ). This suggests that the POZ domain is the functional domain important both in protein-protein interactions with the p65 subunit and in transcription enhancement by FBI-1.
Transcription Activation of NF-B by FBI-1 Is Inhibited by the NF-B Inhibitors PDTC and MG132-We investigated
whether FBI-1 transcription enhancement of NF-B-responsive genes can be directly suppressed by inhibitors of NF-B. MG132 and the antioxidant PDTC are inhibitors of NF-B that work at the level of the proteasome and NF-B, respectively. Cells transfected with the FBI-1 expression plasmid showed ϳ2-3-fold higher luciferase activity, even in the absence of PMA stimulation, compared with control cells (Fig. 5, A and B,  bars 1 and 5) . Treatment of the cells with PDTC or MG132 resulted in repression, probably by inhibiting low levels of free NF-B (Fig. 5, A and B, bars 2 and 6 ). PMA stimulation resulted in strong transcription activation (6-fold increase), and FBI-1 further enhanced transcription by 2-2.6-fold (Fig. 5, A  and B, bars 3 and 7) . Transcription activation by the combined actions of PMA and FBI-1 was completely reversed to the basal level by treatment with PDTC or MG132 (Fig. 5, A and B, bars  4 and 8) . Our data suggest that FBI-1 enhanced the NF-Bresponsive E-selection gene via modulation of NF-B activity, not by direct activation of the E-selection promoter. It appears that FBI-1 may enhance the transcription of NF-B-responsive genes by modulating NF-B, by increasing either the localization or stability of NF-B in the nucleus. First, to determine the cellular localization of the POZ domain and endogenous and overexpressed FBI-1, HeLa cells overexpressing the POZ domain or FBI-1 were incubated with affinity-purified rabbit anti-POZ domain antibody, followed by detection with rhodamine-conjugated anti-rabbit secondary antibody. In control mock-transfected cells, FBI-1 localized mainly in the nucleus, and a low level of FBI-1 was detected in the cytoplasm (Fig. 6A, panel A2 ). Overexpressed FBI-1 was located in the nucleus (Fig. 6A, panel B2) (8) . The POZ domain with no NLS localized mainly in the cytoplasm; the overexpressed POZ domain changed the localization of endogenous FBI-1, trapping FBI-1 in the cytoplasm. In this respect, the POZ domain acted as a dominant-negative form of FBI-1 (Fig.  6A, panel C2) . Because the cellular localization of the POZ domain and FBI-1 was not changed by treatment with the NF-B stimulant PMA (Fig. 6B, panels B1, D1, and F1) , FBI-1 might play a role in the nuclear localization of the p65 subunit of NF-B molecules freed by PMA treatment.
FBI-1 Increases Translocation of the p65 Subunit of NF-B into the Nucleus-Our
The nuclear translocation of NF-B is a key regulatory step in the transcription activation of NF-B-responsive genes. We suspected that FBI-1 might affect the localization of NF-B and thereby enhance transcription. We investigated the cellular localization of p65 after transient overexpression of FBI-1 and the POZ domain to study cellular movement of the proteins. The POZ domain altered the cellular localization of FBI-1 and acted as a dominant-negative mutant for FBI-1 in terms of cellular localization. The cells overexpressing the POZ domain or FBI-1 were incubated with rabbit anti-POZ domain primary antibody, followed by incubation with rhodamine-conjugated anti-rabbit IgG secondary antibody. Cells were also incubated with specific mouse primary antibodies against the NF-B p65 subunit and then further incubated with FITC-conjugated antimouse IgG secondary antibody. In mock-transfected cells, p65 localized in the cytoplasm, and upon stimulation with PMA, p65 was detected in both the cytoplasm and nucleus (Fig. 6B,  panels A2 and B2) . No cell showed intense nuclear localization of p65 in the cells overexpressing FBI-1; p65 localized mainly in the cytosol, as in the control, whereas its concentration might have been slightly increased in the nucleus. However, upon stimulation with PMA, most of the p65 subunit localized intensely in the nucleus, even after 4 h of PMA treatment, in the majority (72%) of cells overexpressing FBI-1 (Fig. 6B, panel  D2) . Although p65 existed both in the nucleus and cytoplasm of control PMA-treated cells, most of the p65 subunit was located in the nucleus in cells overexpressing FBI-1. We also examined the cellular localization of p65 in cells expressing the POZ domain. p65 was detected only in the cytosol, even in the presence of PMA (Fig. 6B, panel F2) , suggesting that the POZ domain trapped free NF-B in the cytosol.
Our data suggest that FBI-1 drastically increased the nuclear localization of the p65 subunit of NF-B even after 4 h of PMA treatment and that the POZ domain prevented the nuclear localization of p65 (Fig. 6 ). This dramatic increase in the nuclear localization of p65 might explain the enhanced transcription of the NF-B-responsive E-selectin gene by FBI-1 (Figs. 2-4) .
FBI-1 Facilitates Nuclear Import of the p65 Subunit of NF-B and Maintains High Levels of Nuclear p65 for a Pro-
longed Period-The increased nuclear localization of the p65 subunit by the combined action of FBI-1 and PMA may increase the transcription of NF-B-responsive genes. The stability of p65 in the nucleus is also important. Other researchers have reported that nuclear NF-B reaches a maximum level at 30 min after TNF␣ stimulation and gradually decreases to basal levels over a 1-h period (33) . Under conditions of persistent stimulation, nuclear NF-B levels oscillate and eventually decrease to about half of the maximum level (33) . As our experiments were carried out under conditions of persistent stimulation with PMA, we investigated, by confocal microscopy, whether overexpressed FBI-1 changes the level of p65 in the nucleus over a 4-h period. In our control experiments, the NF-B level in the nucleus reached its peak at 30 min, quickly decreased over 1-2 h, and decreased to the basal level by 4 h, and very little of the p65 subunit was detected in the nucleus (Fig. 7A, panels A2-F2) . Interestingly, in HeLa cells transfected with FBI-1, the nuclear concentration of the p65 subunit was already very high even at 15 min, and this high level was maintained over a 4-h period in most of the cells overexpressing FBI-1. More than 92% of the cells overexpressing FBI-1 maintained high nuclear p65 levels over a period of 15 min to 1 h. In the majority of cells (Ͼ59%) overexpressing FBI-1, p65 still maintained a high level of nuclear localization without a significant reduction over a 1-4-h period (Fig. 7B) . This observation is quite different from the changes in p65 subunit localization observed in the control cells, where most of the nuclear p65 subunit levels drastically decreased over a 1-4-h period (Fig. 7A) . The fast nuclear import and lasting nuclear retention (Fig. 7C ) of p65 subunits by FBI-1 may explain the more potent transcription activation by NF-B in the presence of PMA and FBI-1 compared with the mock-transfected cells (Fig. 2, B and  C, bar 3) . This novel function of FBI-1 may be important in the NF-B-mediated transcription activation of many genes in tissue or pathological states, where the expression of FBI-1 is increased. thetic dextrose/Gal/Raf/ϪHis/ϪTrp/ϪUra ϩ X-gal and showed strong ␤-galactosidase activity (blue colony formation), suggesting a protein-protein interaction between the POZ domain of FBI-1 and IB␤. In contrast, the control cotransformants of pLexA-POZ FBI-1 /pB42AD and pLexA/pB42AD-IB␤ showed no protein-protein interaction (white colony formation) (Fig. 8A) .
FBI-1 Interacts with IB␣ and IB␤ in Vivo and in Vitro-
We also tested whether the protein-protein interaction between the POZ domain and IB␤ is direct by GST fusion protein pull-down assay. Recombinant GST or GST-IB␤ was incubated with His 6 -POZ, pulled down, and analyzed by Western blotting using anti-His tag antibody. The POZ domain and IB␤ interacted directly. Another member of the IB family, IB␣, also interacted directly with the POZ domain (Fig. 8B) . The fact that the POZ domain directly interacted with both IB␣ and IB␤ suggests that FBI-1 may regulate gene expression involving NF-B probably by modulating the interaction between NF-B and IB proteins most likely in the nucleus, where FBI-1 is primarily located.
DISCUSSION
The POZ domain is a protein-protein interaction motif found in many regulatory proteins and is important in biological processes such as oncogenesis, signal transduction, apoptosis, and osteoclastogenesis (1-3) . The regulatory proteins interacting with the POZ domain include histone deacetylases, N-CoR/ SMRT, B-CoR (Bcl-6 co-repressor), and the Sp1 zinc finger (4, 5, 9) . We have shown here, by co-immunoprecipitation and in vitro and in vivo protein-protein interaction assays, that the POZ domain of FBI-1 interacts with the RHD of the p65 subunit of NF-B. The molecular interaction between the RHD and the POZ domain is important in increasing the nuclear localization of the p65 subunit and the resulting transcription activation of the NF-B-responsive genes.
NF-B plays important roles in many cellular processes such as development, cancer, apoptosis, immune responses, transformation, proliferation, invasion angiogenesis, and metastasis 
FIG. 8. The POZ domain of FBI-1 interacts with IB␣ or IB␤.
A, yeast two-hybrid assay. The POZ domain cDNA was cloned into the pLexA vector, and IB␤ cDNA was cloned into the pB42AD vector. The cotransformants of pLexA-POZ FBI-1 /pB42AD and pLexA/pB42AD-IB␤ showed no protein-protein interaction (white colony formation), but the cotransformant of pLexA-POZ FBI-1 and pB42AD-IB␤ showed proteinprotein interaction (blue colony formation). B, in vitro GST fusion protein pull-down assay. GST, GST-IB␣, and GST-IB␤ bound to agarose beads were incubated with His 6 -POZ and pulled down. Western blot (WB) analysis of the precipitants with anti-His tag antibody (Ab) showed that GST-IB␣ and GST-IB␤ pulled down His 6 -POZ (His-POZ FBI-1 ), suggesting a direct protein-protein interaction between IB␣ or IB␤ and the POZ domain of FBI-1. In contrast, GST (negative control) did not pull down His 6 -POZ. C, Western blot analysis of the same blot using anti-GST antibody showing that the same amounts of GST, GST-IB␣, and GST-IB␤ were used in the pull-down reactions.
of cancer (12) (13) (14) 34) . Accordingly, controlling the activity of NF-B is very important in cellular functions and is the target of intense research investigations. The most well known mechanism of controlling NF-B is through control of the cellular localization of NF-B by IB proteins. IB complexes with NF-B, and NF-B cannot then enter the nucleus because the NLS of NF-B is masked by the interaction between IB and NF-B. Once IB is degraded by ubiquitin-mediated processes, the repression is lifted, and NF-B moves into the nucleus and activates transcription (12) (13) (14) (15) 18) . Newly synthesized IB␣ accumulates in the cytoplasm but also in the nucleus, where it terminates NF-B-dependent transcription. IB␣ inhibits interactions between NF-B and DNA and exports NF-B back to the cytoplasm (19) . There are many other examples of NF-B activity regulation by reversible acetylation, deacetylation, and phosphorylation (21, (35) (36) (37) (38) .
FBI-1 markedly increased the localization and stability of NF-B in the nucleus and thereby increased transcription of the NF-B-responsive E-selectin gene. Cytoplasmic expression of the POZ domain lacking the NLS trapped NF-B in the cytoplasm and inhibited transcription of the NF-B-responsive gene. In contrast, the POZ NLS domain (with the NLS sequence of FBI-1) acted just like FBI-1, enhancing transcription of the E-selectin promoter. FBI-1 may increase the expression of many cellular and viral genes that have NF-B-responsive elements in their promoters by indirect mechanisms (Fig. 9) . The nuclear retention of IB␣ protects it from signal-induced degradation and inhibits NF-B transcription activation (19, 22) . Because the POZ domain of FBI-1 can also interact with IB␣ or IB␤, the interaction may inhibit IB and prevent nuclear FBI-1 from being exported to the cytoplasm (Fig. 9) . In this respect, FBI-1 may antagonize transcription repression by IB in the nucleus by interaction with the RHD of the p65 subunit and IB proteins via the N terminus of the POZ domain (Figs. 3 and 9 ). Our investigation may provide a novel mechanism of transcription activation that involves NF-B, FBI-1, and possibly IB.
We found that FBI-1 enhanced transcription most notably in the presence of PMA. This suggests that the primary function of FBI-1 was to trap the p65 subunit of NF-B in the nucleus once the p65 subunit moved into the nucleus after the ubiquitin/proteasome-mediated degradation of IB proteins. The ubiquitous transcription factor FBI-1 might also be important in maintaining the transcription of many genes with NF-Bresponsive elements by sustaining a low nuclear level of NF-B in the absence of immunostimulant. Also, under conditions in which FBI-1 is highly expressed and immunostimulants exist, the potent transcription activation of NF-B-responsive genes is possible due to the nuclear trapping of the p65 subunit by FBI-1 (Fig. 9) .
Although the POZ domain used in our experiments does not exist in normal human cells, there are many proteins that contain only the POZ domain at their N termini. There are Ͼ300 POZ domain proteins, and although some of the proteins tested here did not show the same potent regulatory effect as FBI-1, some may possibly be involved in regulating NF-Bmediated biological processes by controlling the cellular localization of the NF-B family of proteins.
In particular, NF-B activation mediates cellular transformation and proliferation, invasion angiogenesis, and metastasis of cancer (35) . SAGE data from the NCBI Protein Database show that FBI-1 is highly expressed in carcinoma and adenocarcinoma cell lines. FBI-1 may play a role in cancer metastasis because FBI-1 potently increases the localization and stability of the p65 subunit of NF-B in the nucleus and because FBI-1 increases the expression of NF-B-responsive genes such as E-selectin, which was shown to be an important protein in tumorigenesis and metastasis.
